Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1 g) - injection, powder for - excipient ingredients: sodium carbonate - meropenem ranbaxy is indicated for the treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: - community acquired lower respiratory tract infection, - hospital acquired lower respiratory tract infection, - complicated urinary tract infection, - febrile neutropenia, - intra-abdominal and gynaecological (polymicrobial) infections,- complicated skin and skin structure infections, - meningitis, - septicaemia.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

ranbaxy australia pty ltd - meropenem trihydrate -

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 300 milligram

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 75 milligram

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 150 milligram

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 75 milligram

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 150 milligram

Írland - enska - HPRA (Health Products Regulatory Authority)

ranbaxy ireland limited - irbesartan - film coated tablet - 300 milligram

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lisinopril dihydrate -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lisinopril dihydrate -